Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Teachers' emotional well-being during the SARS-CoV-2 pandemic with long school closures: a large-scale cross-sectional survey in Northern Italy.

Public health·2022

Same author

[Albumin in traumatic brain injury-many unanswered questions!]

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2022

Same author

Acute kidney injury in critically burned patients treated with hydroxyethyl starch: a response to Sánchez-Sánchez et al.

Annals of burns and fire disasters·2018

Same author

Weekend effects on health outcomes and operational efficiency in emergency admissions to general medicine services of the Central Hospital of the Autonomous Province of Bolzano, Italy.

Annali di igiene : medicina preventiva e di comunita·2018

Same author

Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited.

Journal of thrombosis and haemostasis : JTH·2018

Same author

Impairment of innate immune function by hydroxyethyl starch.

British journal of anaesthesia·2016

Search research articles

Related Experiment Video

Updated: May 28, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

[Volume replacement therapy options for critically ill patients].

C J Wiedermann¹

¹Abteilung für Innere Medizin, Zentralkrankenhaus Bozen, Italien. christian.wiedermann@asbz.it

Medizinische Klinik, Intensivmedizin Und Notfallmedizin

|October 7, 2011

Summary

This summary is machine-generated.

Volume replacement therapy is crucial for critically ill patients. Crystalloids are cost-effective but can cause edema, while colloids are efficient but more expensive and carry anaphylaxis risks.

Related Experiment Videos

Last Updated: May 28, 2026

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Area of Science:

Critical Care Medicine
Fluid Resuscitation
Pharmacology

Background:

Volume replacement therapy is essential for maintaining tissue perfusion and oxygenation in critically ill patients with hypovolemia.
Crystalloids and colloids are commonly administered fluids, each with distinct properties and clinical implications.

Purpose of the Study:

To compare the efficacy and safety of crystalloids versus colloids in fluid replacement therapy for critically ill patients.
To analyze the advantages and disadvantages of different fluid types in managing hypovolemia.

Main Methods:

Review of existing literature on fluid resuscitation strategies in critical care.
Analysis of crystalloid properties (cost, availability, fluid distribution, allergenicity) and potential adverse effects (edema).
Evaluation of colloid properties (volume expansion efficiency, edema prevention) and associated risks (cost, anaphylaxis).

Main Results:

Crystalloids are inexpensive and widely available, distributing into both intravascular and extravascular spaces, but excessive administration can lead to tissue edema.
Colloids offer more efficient volume expansion, potentially avoiding edema, but are costlier and carry a risk of rare anaphylactic reactions.
Artificial colloids like hydroxyethyl starch are cheaper than albumin but have a less favorable safety profile.

Conclusions:

The choice between crystalloids and colloids involves balancing efficacy, cost, and safety profiles.
Careful fluid management is necessary to optimize tissue perfusion while minimizing adverse effects like edema and anaphylaxis.
Further research may be needed to clarify the optimal use of different fluid types in specific critical care scenarios.